RaySearch Laboratories AB

Equities

RAY B

SE0000135485

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 12:00:00 2024-07-11 pm EDT 5-day change 1st Jan Change
136 SEK -0.44% Intraday chart for RaySearch Laboratories AB -0.73% +50.61%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
RaySearch Releases RayStation 2024B CI
RaySearch Laboratories AB Releases RayCare 2024A CI
Raysearch Laboratories AB Apprves Ordinary Dividend for the Year 2023 CI
Ordinary Dividend Approves Extra Dividend for the Year 2023 CI
Transcript : RaySearch Laboratories AB, Q1 2024 Earnings Call, May 17, 2024
RaySearch Laboratories AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
C-RAD Partners with RaySearch Laboratories to Improve Radiation Therapy MT
RaySearch Laboratories AB and C-RAD Sign Collaboration Agreement CI
Raysearch to Present the Latest Advances in Raystation, Raycare and Rayintelligence At Estro 2024 CI
National Institutes for Quantum Science and Technology Selects RaySearch Laboratories AB for Clinical Use at the QST Hospital CI
Transcript : RaySearch Laboratories AB, 2023 Earnings Call, Feb 23, 2024
RaySearch Laboratories AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
RaySearch Laboratories AB Proposes an Extra Dividend for the Year Ended December 31, 2023, Payable on May 29, 2024 CI
RaySearch Laboratories AB Proposes Ordinary Dividend for the Year Ended December 31, 2023, Payable on May 29, 2024 CI
Pharmacolog Sells Druglog Product Line to RaySearch Laboratories MT
RaySearch Laboratories AB (OM:RAY B) acquired product line Druglog of Pharmacolog AB for SEK 8.5 million. CI
The Royal Marsden Nhs Foundation Trust to Implement Online Adaptiation Therapy Utilizing Artemis from Raysearch CI
The Froedtert & Medical College of Wisconsin Health Network Selects RayStation CI
RaySearch Laboratories AB Releases Raystation 2024A CI
Vejle Hospital Becomes First Center in the World to Use RayStation for an Online Adaptive Treatment with Augmented CBCT CI
Transcript : RaySearch Laboratories AB, Q3 2023 Earnings Call, Nov 17, 2023
RaySearch Laboratories AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Oregon Health & Science University to Utilize RayStation Technology for Radiation Therapy Planning CI
Baptist Health Lexington Selects RayStation CI
Prominent U.S. Hospital Expands Raystation Installation for Proton Treatment Planning CI
Chart RaySearch Laboratories AB
More charts
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
136.6 SEK
Average target price
195 SEK
Spread / Average Target
+42.75%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RAY B Stock
  4. News RaySearch Laboratories AB
  5. RaySearch Laboratories Deputy CEO Takes on Interim CFO Role